Professor, Neurology, University of Washington School of Medicine
Neurology
Dr. Christina M. Marra, MD
|
|
Give Review
Dr. Christina M. Marra practices Neurology. She went to medical school at Oregon Health & Science University School of Medicine. She received awards:"Regional Top Doctor". Doctor Christina M. Marra, MD is a published MD. She has 100 papers published. The most current publication "Diagnostic accuracy of HIV-associated central nervous system toxoplasmosis." Dr. Christina M. Marra is registered with Medicare and accepts Medicare payments.
Publications
- Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.
- Predictors of new-onset distal neuropathic Pain in HIV-infected individuals in the era of combination antiretroviral therapy.
- Reply to Haddow et al.
- Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.
- Point-of-Care Treponemal Tests for Neurosyphilis Diagnosis.
- Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.
- Abdominal Obesity Contributes to Neurocognitive Impairment in HIV Infected Patients with Increased Inflammation and Immune Activation.
- Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.
- Toll-like receptor polymorphisms are associated with increased neurosyphilis risk.
- Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.
- Headache in HIV-Infected Patients: Much to Consider.
- HIV-associated distal neuropathic pain is associated with smaller total Cerebral cortical gray matter.
- Central Nervous System Diseases due to Opportunistic and Coinfections.
- Increases in Brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection.
- Neurocognitive impairment in HIV-infected individuals with previous syphilis.
- Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.
- Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive Disorders.
- Etravirine in CSF is highly protein bound.
- Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-associated Neurocognitive Disorders in the CHARTER Cohort.
- Two Mutations Associated With Macrolide Resistance in Treponema pallidum: Increasing Prevalence and Correlation With Molecular Strain Type in Seattle, Washington.
- Diagnostic dilemma of a young man with Fever and Headaches.
- The rapid plasma reagin test cannot replace the venereal Disease research laboratory test for neurosyphilis diagnosis.
- Lifetime suicidal ideation and attempt are common among HIV+ individuals.
- Cerebrovascular Disease in central nervous system infections.
- Stroke in a Patient With Human Immunodeficiency Virus and Syphilis Treated With Penicillin and Antiretroviral Therapy.
- Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis.
- Ocular syphilis among HIV-infected individuals.
- CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
- Depletion of B lymphocytes from Cerebral perivascular spaces by rituximab.
- Update on neurosyphilis.
- Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis.
- Isolation and laboratory maintenance of Treponema pallidum.
- Déjà vu all over again: when to perform a lumbar puncture in HIV-infected patients with syphilis.
- Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.
- Proton MRS and neuropsychological correlates in AIDS Dementia complex: evidence of subcortical specificity.
- Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum.
- Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with Multiple sclerosis.
- Immune surveillance in Multiple sclerosis patients treated with natalizumab.
- Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model.
- Regional patterns of Brain metabolites in AIDS dementia complex.
- Syphilis and human immunodeficiency virus: prevention and politics.
- Macrolide resistance in Treponema pallidum in the United States and Ireland.
- Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter?
- Relapse of secondary syphilis after benzathine penicillin G: molecular analysis.
- Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features.
- Update on syphilis: resurgence of an old problem.
- A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.
- Neurocognitive impact of substance use in HIV infection.
- Family history of Dementia predicts worse neuropsychological functioning among HIV-infected persons.
- HIV-associated neurocognitive Disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
- The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America.
- Memantine for AIDS Dementia complex: open-label report of ACTG 301.
- Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory Neuropathy in the era of combination antiretroviral therapy: t...
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.
- Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.
- Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.
- A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people.
- A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory Neuropathy.
- Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
- Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
- A multi-center 1H MRS study of the AIDS Dementia complex: validation and preliminary analysis.
- A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.
- Hearing loss and antiretroviral therapy in patients infected with HIV-1.
- Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection.
- A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals.
- Mechanisms of clearance of Treponema pallidum from the CSF in a nonhuman primate model.
- Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals.
- Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy.
- Selegiline and oxidative stress in HIV-associated cognitive impairment.
- HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.
- A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.
- Updated research nosology for HIV-associated neurocognitive Disorders.
- The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection.
- Cerebrospinal fluid treponemal antibodies in untreated early syphilis.
- Screening for distal sensory peripheral Neuropathy in HIV-infected persons in research and clinical settings.
- Central nervous system manifestations in human immunodeficiency virus infection without AIDS.
- Cognitive risk factors and neuropsychological performance in HIV infection.
- Prospective Cerebral MR study of HIV seropositive and seronegative men: correlation of MR findings with neurologic, neuropsychologic, and cerebrospinal fluid analysis.
- Alterations in the course of experimental syphilis associated with concurrent simian immunodeficiency virus infection.
- Clinical factors related to Brain structure in HIV: the CHARTER study.
- Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1.
- An experimental model of early central nervous system syphilis.
- HIV-associated neurocognitive Disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
- A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
- Second assessment of NeuroAIDS in Africa.
- A randomized trial of amitriptyline and mexiletine for painful Neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.
- HIV Neuropathy natural history cohort study: assessment measures and risk factors.
- Detection of Treponema pallidum by a sensitive reverse transcriptase PCR.
- Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.
- A multicenter in vivo proton-MRS study of HIV-associated Dementia and its relationship to age.
- Comparison of methods for the detection of treponema pallidum in lesions of early syphilis.
- Diagnostic accuracy of HIV-associated central nervous system toxoplasmosis.
- The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the centra...
- Progressive multifocal leukoencephalopathy presenting as human immunodeficiency virus type 1 (HIV)-associated Dementia.
- Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory Neuropathy.
- Effects of traumatic Brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals.
- Evaluation of aqueous penicillin G and ceftriaxone for experimental neurosyphilis.
- Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study.
- Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in Multiple sclerosis patients.
Schools
Oregon Health Sciences University
University Of Wa School Of Med
University Wa Med Center
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Brain Aneurysm
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Washington -
Oregon Health & Science University School of Medicine
Hospital
-
UW Medicine/Harborview Medical Center -
UW Medicine/Northwest Hospital & Medical Center -
University of Washington Medical Center
Drug Facts
| NPI NUMBER | 1619005691 | |
| NPPES Provider LastName | MARRA | |
| NPPES Provider FirstName | CHRISTINA | |
| NPPES Provider ZIPCode | 981042420 | |
| NPPES Provider State | WA | |
| Specialty Description | Neurology | |
| Total Claim Count | 167.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619005691 |
| Last Name Of The Provider | MARRA |
| First Name Of The Provider | CHRISTINA |
| View All |
Similar Doctors
|
|
Dr. Richard A. Mesher, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ian Merrill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary E. Reif, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary H. Shwetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Russell, MD |
|
|
Dr. Allen S. Nielsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juan A. Piantino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan J. Velander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn A. Roberts, MD |
|
|
Dr. James B. Leverenz, MD
This Doctor is OpenDoctor Recommended.
|